Tradestie Institutional Equity Comparison Engine
KMTS vs LMRI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KMTS Overall Edge
KMTS Captures Institutional Edge (1โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kestra Medical Technologies, Ltd. Common Stock (KMTS) driven by superior Growth & Margin while LMRI counters with relative strength in Momentum & Technical. Fundamentally, KMTS trades at N/M Forward P/E with -134.5% operating margin (+59.9% YoY revenue) versus LMRI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
KMTS N/M vs LMRI N/M Fwd P/E
Growth & Margin Winner
KMTS
Op Margin -134.5% vs N/A ยท YoY +59.9% vs N/A
Momentum & Technical Winner
LMRI
1Y -2.8% vs -23.0% ยท 52W Pos 53% vs 60%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KMTS
NASDAQ
Kestra Medical Technologies, Ltd. Common Stock
Surgical & Medical Instruments & Apparatus
$25.10
-5.75% 1D
Market Cap
$1.6B
1M Return
-11.37%
1Y Return
-2.83%
Forward P/E
N/M
Unified AI Score
46.9 / 100
HOLD
Tech 37.0
Fund 43.0
Flow 50.0
Mom 60.0
LMRI
US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap
N/A
1M Return
+30.95%
1Y Return
-23.0%
Forward P/E
N/M
Unified AI Score
32.1 / 100
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KMTS -2.83%
LMRI -23.0%
Spread: +23.76 pp (KMTS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
KMTS TTM Op. Margin: -134.5%
LMRI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KMTS vs LMRI. Trailing 12-month operating profitability (KMTS -134.5% vs LMRI N/A) and valuation multiples (KMTS N/M vs LMRI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KMTS | LMRI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | N/A | Larger Scale | KMTS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +59.9% | N/A | Higher Growth | KMTS |
| Operating Margin (TTM) Profitability | -134.5% | N/A | Higher Margin | KMTS |
| Net Profit Margin Profitability | -140.4% | N/A | Higher Margin | KMTS |
| Return on Equity (ROE) Capital Efficiency | -73.7% | N/A | Higher ROE | KMTS |
| 52-Week Range Position Momentum | 53% ($17โ$32) | 60% ($6โ$19) | Stronger Trend | LMRI |
| Beta / 30D Volatility Risk Regime | 1.74ฮฒ ยท 63% Vol | 1.22ฮฒ ยท 85% Vol | Lower Realized Risk | KMTS |
| Unified Institutional Score Composite Signal | 46.9 / 100 (HOLD) | 32.1 / 100 (SELL) | Higher Composite | KMTS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KMTS vs LMRI Buy Guide
KMTS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
LMRI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KMTS nor LMRI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.